Clinical Trials
Codexis Doses First Subjects in Phase 1a Trial of...
Codexis, Inc , a leading protein engineering company, announces that it has dosed the first subjects in a first-in-human Phase 1a dose-escalation trial with CDX-6114,...
Clinical Trials
Aminex Therapeutics Initiates First Clinical Trial of Novel Immunotherapy...
Aminex Therapeutics, Inc., a clinical-stage drug development company focused on advancing a novel cancer immunotherapy, announced it received clearance from the FDA to initiate the...
Clinical Trials
MEI Pharma Presents Phase 1b Clinical Data for ME-401...
MEI Pharma, Inc a pharmaceutical company focused on leveraging its extensive development and oncology expertise to identify and advance new therapies for cancer. ...
Clinical Trials
AstraZeneca provides update on GALATHEA Phase III trial for...
AstraZeneca and MedImmune, its global biologics research and development arm, announced top-line results from the GALATHEA Phase III trial for Fasenra (benralizumab) in patients with...
Clinical Trials
Medigene AG: Medigene’s Academic Partners Provide Update on Planned...
Planegg (pta/08.05.2018/07:30) Medigene AG (MDG1, Frankfurt, Prime Standard), announced that researchers from Max-Delbrück-Center for Molecular Medicine (MDC) and Charité, both in Berlin, Germany, will present...
Clinical Trials
Nordic Nanovector Presents Preclinical Data at AACR 2018
Nordic Nanovector ASA announces that a poster reporting the anti-tumour effect of Humalutin® (177Lu-conjugated humanized anti-CD37 antibody, 177Lu-NNV003) in preclinical models of non-Hodgkin's lymphoma (NHL)...
Clinical Trials
Apitope Announces Positive Results with Novel Treatment for Graves’...
Apitope, a clinical stage biotech company developing potential first-in-class antigen-specific immunotherapies targeting autoimmune diseases (including multiple sclerosis (MS), Graves' disease and uveitis), announced positive results...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.